25 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
, damages, fines, imprisonment, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, reputational harm … in substantial cost and reputational loss and be a distraction to our management and other employees. In addition, while it is our policy to require our
ARS
ug7im
28 Apr 23
Annual report to shareholders
7:03am
424B4
5d8aw1o43w52cfx37 q4
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
9d0ki5n
19 May 21
Draft registration statement
12:00am
10-K
z7jy7nzs2 diedii4k
11 Mar 21
Annual report
4:19pm
10-Q
hy0njip8i2y
12 Nov 20
Quarterly report
4:28pm
424B4
j5yuj
2 Oct 20
Prospectus supplement with pricing info
5:10pm